Conclusion: GSTM3 inhibited tumor progression and altered the metabolic pattern in PC
In the past, medications such as ACE inhibitors and calcium channel blockers were used as primary therapy for these patients
Based on UK data from the NBSR and BOMSS, patients can anticipate the following expected outcomes : Excess weight loss of approximately 5070% within the first 1218 months post-operatively, though results vary by centre and individual factors [11] Significant improvement or remission of obesity-related comorbidities, including type 2 diabetes (remission rates broadly in the range of 5060% at one to two years), hypertension, dyslipidaemia, and obstructive sleep apnoea [11] Improved quality of life, mobility, and psychological wellbeing Reduced long-term cardiovascular risk However, as with any surgical procedure, sleeve gastrectomy carries risks that must be clearly communicated during the consent process
2023 [40] conducted a post hoc analysis of the Harmony trial evaluating the effect of albiglutide versus placebo on reducing cardiovascular events in patients with T2DM and CVD with background use of SGLT-2is
Patients were followed up for 180 days from the end of the wash-out period
It may enhance skin repair and reduce the appearance of scars and wrinkles